rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

David F. Clanachan

Director

Company insider

Files Form 4 as: Director, Tilray Brands; COO, U.S. and International, Tim Hortons.

Every Form 4 they filed

In numbers

Trades disclosed
59
Buys
1
Sells
1
Bought
$880K
Sold
$689K
Companies
2
Companies where not an officer
1
First trade
24 Mar 2006
Last trade
29 Jul 2026
Last filed
30 Jul 2026

Companies traded

Where they are an officer
Tim HortonsOfficer · last 15 May 20091 buy · 1 sell
Everywhere else they filed: board seats, 10% stakes, other companies
TLRY Tilray BrandsDirector · Pharmaceuticals · last 29 Jul 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
29 Jul 2026filed 30 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—43,104 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$86K21,552 at $3.99filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—43,104 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—43,104 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—62,657 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—62,657 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—43,104 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$86K21,552 at $3.99filing
30 Jul 2025filed 31 Jul 2025TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—124,378 at $0.00filing
30 Jul 2025filed 31 Jul 2025TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M$76K124,378 at $0.61filing
30 Jul 2025filed 31 Jul 2025TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$40K65,921 at $0.61filing
29 Jul 2025filed 31 Jul 2025TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—431,034 at $0.00filing
30 Jul 2024filed 30 Jul 2024TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—124,378 at $0.00filing
26 Jul 2024filed 30 Jul 2024TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code D—129,543 at $0.00filing
26 Jul 2024filed 30 Jul 2024TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M$237K129,534 at $1.83filing
26 Jul 2024filed 30 Jul 2024TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$119K64,962 at $1.83filing
21 Jun 2024filed 24 Jun 2024TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—3,858 at $0.00filing
21 Jun 2024filed 24 Jun 2024TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M$6,4043,858 at $1.66filing
21 Jun 2024filed 24 Jun 2024TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code F$3,2121,935 at $1.66filing
26 Jul 2023filed 27 Jul 2023TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code D—70,621 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.